PHASTAR Blog Reviewing and Updating the Statistical Analysis Plan and Creating Mock Shells as Part of the Phastar CARES Scheme

Phastar is providing pro-bono support to Medicines Development for Global Health (MDGH) as part of its Phastar CARES scheme. Phastar's biometrics experts supported the statistical analysis plan (SAP) updates for two related studies on the treatment of onchocerciasis.Study detailsMDGH, a not for profit biopharmaceutical organization developing medicines for neglected diseases primarily affecting people living in poverty, is running two related studies examining the safety and efficacy of moxidectin as a treatment for onchocerciasis (also known as river blindness).